Lv3
312 积分 2025-04-22 加入
Avidity in antibody effector functions and biotherapeutic drug design
8小时前
已完结
Siglec-9 acts as an immune-checkpoint molecule on macrophages in glioblastoma, restricting T-cell priming and immunotherapy response
14天前
已完结
CD47-SIRPα Blockade Sensitizes Head and Neck Squamous Cell Carcinoma to Cetuximab by Enhancing Macrophage Adhesion to Cancer Cells
2个月前
已完结
Avidity in antibody effector functions and biotherapeutic drug design
2个月前
已完结
Nox2-Mediated PI3K and Cofilin Activation Confers Alternate Redox Control of Macrophage Pinocytosis
3个月前
已完结
Lack of a correlation between radiosensitivity and DNA double-strand break induction or rejoining in six human tumor cell lines
5个月前
已完结
Daratumumab, a Novel Therapeutic Human CD38 Monoclonal Antibody, Induces Killing of Multiple Myeloma and Other Hematological Tumors
6个月前
已完结
Phase III Study of R-CVP Compared With Cyclophosphamide, Vincristine, and Prednisone Alone in Patients With Previously Untreated Advanced Follicular Lymphoma
7个月前
已完结
Overview of the clinical development of rituximab: first monoclonal antibody approved for the treatment of lymphoma
7个月前
已关闭
Trastuzumab — Mechanism of Action and Use in Clinical Practice
7个月前
已完结
皖公网安备34019202002308
